3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
29
Phase 1
21
Phase 1/2
14
Phase 3
6
Phase NA
2
Phase EARLY_PHASE1
1
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Breast Neoplasms
39
Glioblastoma
37
Glioma
33
Prostatic Neoplasms
32
Neoplasms
28
Multiple Myeloma
26
Pancreatic Neoplasms
25
Brain Neoplasms
23
Colorectal Neoplasms
19
Recurrence
18
Squamous Cell Carcinoma of Head and Neck
16
Melanoma
15
Lung Neoplasms
15
Neoplasm Metastasis
14
Lymphoma, B-Cell
13
Lymphoma
13
Carcinoma, Non-Small-Cell Lung
13
Triple Negative Breast Neoplasms
12
Sarcoma
12
Leukemia, Myeloid, Acute
12
Hematologic Neoplasms
12
Head and Neck Neoplasms
12
Advanced Solid Tumors
10
Stomach Neoplasms
9
Ovarian Neoplasms
9
Skin Neoplasms
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Neuroblastoma
8
Lymphoma, Non-Hodgkin
8
Colonic Neoplasms
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Leukemia, Biphenotypic, Acute
×
1 year
×
Clear all
NCT03957915
2025-08-06
INA03
Institut Paoli-Calmettes
Phase EARLY_PHASE1
Completed
33 enrolled